After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
DXCM belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. The current market capitalization of Dexcom Inc is $31.40B. A total of 4.77 million shares were traded on the day, compared to an average of 3.96M shares.
In the most recent transaction, Stern Sadie sold 424 shares of DXCM for 76.87 per share on Dec 16 ’24. After the transaction, the EVP, Chief HR Officer now owns 70,768 company shares. In a previous transaction on Dec 16 ’24, Sylvain Jereme M sold 744 shares at 76.87 per share. DXCM shares that EVP, Chief Financal Officer owns now total 80,030.
Among the insiders who sold shares, Leach Jacob Steven disposed of 744 shares on Dec 16 ’24 at a per-share price of $76.87. This resulted in the EVP, Chief Operating Officer holding 264,171 shares of DXCM after the transaction. In another insider transaction, Heller Bridgette P sold 1,000 shares at $76.87 per share on Dec 16 ’24. Company shares held by the Director now total 23,349.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, DXCM has a high of $142.00 and a low of $62.34.
As of this writing, DXCM has an earnings estimate of $0.51 per share for the current quarter. EPS was calculated based on a consensus of 20.0 estimates, with a high estimate of $0.59 per share and a lower estimate of $0.41.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. DXCM’s latest balance sheet shows that the firm has $2.73B in Cash & Short Term Investments as of fiscal 2021. There were $2.16B in debt and $720.80M in liabilities at the time. Its Book Value Per Share was $5.07, while its Total Shareholder’s Equity was $2.04B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DXCM is Buy with a score of 4.50.
